|
|||||
|
|
Roadzen Posts First ‘Rule of 40’ Quarter in Two Years; FY2026 Net Loss Narrows 69% and Adjusted EBITDA Loss Improves 58%, with Seventh Straight Quarter of Adjusted EBITDA Gains Nearing Breakeven
_______________________
1 Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.
NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the Fiscal 2026 fourth quarter and full year ended March 31, 2026.
Commenting on the Company's results, Rohan Malhotra, Founder and CEO of Roadzen, stated, "This was the best quarter in our history. We have been building towards this growth for two years by laying the groundwork — we are seeing increased adoption of our platform, largely driven by the U.S. and India, and democratic growth across all of our product lines. More customers are adopting more of our platform, across more geographies, and at increasing speed.
We are showcasing real-world AI at scale. Unlike general intelligence models, which are large, expensive and general-purpose, our focus is on building specialized models that deliver enterprise intelligence within context — that are built for precision and the lowest cost of delivery, so that our accuracy translates directly into real economic impact for our customers. As adoption grows, the network effects across our data, distribution, and decisioning compound.
Our goal for this year is clear: to be one of a handful of AI companies, globally, with over $100 million in annual recurring revenue with adjusted EBITDA profitability, and growing more than 40-50% a year. We are still early, but the direction is clear, and we have entered Fiscal 2027 with more momentum, more visibility, and greater conviction than ever before."
Roadzen's CFO, Jean-Noël Gallardo, commented, "The Fiscal fourth quarter represented a clear acceleration in Roadzen's financial trajectory, with record quarterly revenue growing 42% year-over-year and 12% sequentially, driving meaningful operating leverage and continued improvement in our financial metrics. While our net loss for the quarter was $(7.3) million, or $(0.09) per share, we reduced our full-year Fiscal 2026 net loss by approximately 69% over the prior year. Our Adjusted EBITDA loss narrowed to $(0.4) million — our seventh consecutive quarter of improvement — bringing the Company closer to Adjusted EBITDA breakeven. We are also exceptionally pleased to report our first ‘Rule of 40’ quarter since the U.K. pause. The growth we are seeing in our acquired businesses is being driven by the synergies we have created across the Roadzen platform — by connecting them to our AI, our distribution, and our customer base, we are accelerating their growth well beyond what they could achieve independently.
There is clear momentum in the operating performance of the business, where year-over-year revenue growth has accelerated from an average of 18% in the first half of this year to more than 30% growth in the second half, while our Adjusted EBITDA margin narrowed from -10.2% to -3.3% over the same period — showing both sustained commercial acceleration and a clear trend toward breakeven.
We also made decisive improvements to our balance sheet. We reduced short-term borrowings by approximately 60%, from $19.9 million to $7.8 million, while extending into longer-duration debt — including the extension of our $11.5 million senior secured facility with Mizuho to July 2027 — strengthening our near-term liquidity position and capital flexibility. We raised capital almost entirely through clean equity, largely at a premium to our market price, including at the India subsidiary level. The balance sheet clean-up remains a focus for us as we continue to strengthen the foundations of the business."
Fourth Quarter and Full Year Financial Highlights
P&L
Revenue and Key Performance Indicators:
Net Results:
Balance Sheet
Assets:
Liabilities:
Capitalization:
drivebuddyAI Developments:
Acquisitions: Strategic Acquisitions Unlock New Markets and Full-Stack Control
FY2027 – Off to a Strong Start with Over $30 Million in New Annual Revenue Mandates
Financial Developments
Revenue & Commercial Deployments:
Strategic Partnerships & Ecosystem Expansion:
Other Interest:
For more information about Roadzen Inc., please visit https://roadzen.ai.
About Roadzen Inc. Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world's leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world's top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India, and China. Learn more at www.roadzen.ai.
Cautionary Statement Regarding Forward Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," and "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, our expected revenue growth and anticipated Adjusted EBITDA breakeven timing, expected revenue and results from announced contracts and strategic partnerships, the anticipated synergies and growth from our acquisitions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in "Risk Factors" in our Securities and Exchange Commission ("SEC") filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact: Investor Contacts: IR@roadzen.ai Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai
Financial Statements Follow
| Roadzen Inc. | ||||
| Consolidated Balance Sheets | ||||
| (in US $, except share count) | ||||
| Particulars | ||||
| As of March 31, 2026 | As of March 31, 2025 | |||
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | 6,578,594 | 4,836,576 | ||
| Accounts receivable, net | 7,500,439 | 2,625,385 | ||
| Inventories | 116,555 | 202,535 | ||
| Prepayments and other current assets | 17,833,119 | 19,092,595 | ||
| Investments | 229,994 | 197,805 | ||
| Total current assets | 32,258,701 | 26,954,896 | ||
| Non current assets | ||||
| Restricted cash | 222,026 | 217,064 | ||
| Non marketable securities | - | 269,470 | ||
| Property and equipment, net | 536,997 | 602,923 | ||
| Goodwill | 7,616,973 | 2,061,553 | ||
| Operating lease right-of-use assets | 1,374,147 | 1,109,219 | ||
| Intangible assets, net | 9,651,915 | 1,243,253 | ||
| Other long-term assets | 997,802 | 120,972 | ||
| Total Non current assets | 20,399,860 | 5,624,454 | ||
| Total assets | 52,658,561 | 32,579,350 | ||
| Liabilities and shareholders' Equity/(Deficit) | ||||
| Current liabilities | ||||
| Current portion of long-term borrowings | 9,829,713 | 2,904,444 | ||
| Short-term borrowings | 7,843,267 | 19,865,645 | ||
| Accounts payable and accrued expenses | 30,245,947 | 30,254,010 | ||
| Derivative warrant liabilities | 1,987,003 | 1,489,818 | ||
| Short-term operating lease liabilities | 325,255 | 318,921 | ||
| Other current liabilities | 8,072,789 | 2,102,466 | ||
| Total current liabilities | 58,303,974 | 56,935,304 | ||
| Non current liabilities | ||||
| Long-term borrowings | 15,612,108 | 139,775 | ||
| Long-term operating lease liabilities | 699,817 | 628,400 | ||
| Other long-term liabilities | 4,561,246 | 566,651 | ||
| Total Non current liabilities | 20,873,171 | 1,334,826 | ||
| Total liabilities | 79,177,145 | 58,270,130 | ||
| Commitments and contingencies (refer note 22) | ||||
| Shareholders' Equity/(Deficit) | ||||
| Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of March 31, 2026 and March 31, 2025; 79,695,672 and 74,290,986 shares outstanding as of March 31, 2026 and March 31, 2025 respectively | 112,128,293 | 95,501,291 | ||
| Accumulated deficit | (246,224,660 | ) | (223,826,442 | ) |
| Accumulated other comprehensive income/(loss) | (1,299,868 | ) | (468,859 | ) |
| Other components of equity | 105,747,998 | 103,720,113 | ||
| Total shareholders’ deficit | (29,648,237 | ) | (25,073,897 | ) |
| Non-controlling interest | 3,129,653 | (616,883 | ) | |
| Total deficit | (26,518,584 | ) | (25,690,780 | ) |
| Total liabilities and Total Deficit | 52,658,561 | 32,579,350 | ||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||
| Roadzen Inc. | ||||||||
| Consolidated Statements of Operations | ||||||||
| (in US $, except share count) | ||||||||
| Particulars | For the three months ended March 31, | For the year ended March 31, | ||||||
| 2026 | 2025 | 2026 | 2025 | |||||
| Revenue | 16,121,304 | 11,330,827 | 55,021,792 | 44,296,098 | ||||
| Costs and expenses: | ||||||||
| Cost of services | 5,537,522 | 3,893,120 | 21,277,579 | 18,833,218 | ||||
| Research and development | (115,664 | ) | 244,928 | 408,355 | 3,779,955 | |||
| Sales and marketing | 9,349,677 | 7,133,481 | 29,111,662 | 28,873,150 | ||||
| General and administrative | 6,069,343 | 2,694,733 | 15,976,982 | 51,602,107 | ||||
| Depreciation and amortization | 1,057,462 | 1,046,539 | 2,244,268 | 2,020,610 | ||||
| Total costs and expenses | 21,898,341 | 15,012,801 | 69,018,846 | 105,109,040 | ||||
| Loss from operations | (5,777,037 | ) | (3,681,974 | ) | (13,997,054 | ) | (60,812,942 | ) |
| Interest expense (net) | (1,871,764 | ) | (714,899 | ) | (7,249,803 | ) | (3,247,831 | ) |
| Gain on bargain purchase | 174,248 | — | 174,248 | — | ||||
| Fair value gains/(losses) in financial instruments carried at fair value | 635,187 | 1,681,725 | (3,984,386 | ) | (14,844,420 | ) | ||
| Impairment of investment | (269,470 | ) | (1,245,326 | ) | (269,470 | ) | (1,245,326 | ) |
| Other income (net) | (193,775 | ) | 3,861,541 | 2,329,515 | 7,073,235 | |||
| Total other income/(expense) | (1,525,574 | ) | 3,583,041 | (8,999,896 | ) | (12,264,342 | ) | |
| Loss before income taxes and equity-method investment activity | (7,302,611 | ) | (98,933 | ) | (22,996,950 | ) | (73,077,284 | ) |
| Equity method investment activity, net | — | — | — | — | ||||
| (Loss)/Income before income tax expense | (7,302,611 | ) | (98,933 | ) | (22,996,950 | ) | (73,077,284 | ) |
| Less: income tax (benefit)/expense | (46,966 | ) | 69,709 | 20,212 | (13,973 | ) | ||
| Net (loss)/income before non-controlling interest | (7,255,645 | ) | (168,642 | ) | (23,017,162 | ) | (73,063,311 | ) |
| Net loss attributable to non-controlling interest, net of tax | (1,733 | ) | (61,675 | ) | (500,940 | ) | (192,879 | ) |
| Net Loss attributable to Ordinary shareholders | (7,253,912 | ) | (106,967 | ) | (22,516,222 | ) | (72,870,432 | ) |
| Net loss per share attributable to Ordinary shareholders | ||||||||
| Basic and diluted | (0.09 | ) | (0.00 | ) | (0.29 | ) | (1.04 | ) |
| Weighted-average number of shares used in computing net loss per share | 79,673,597 | 68,882,560 | 77,454,509 | 69,867,792 | ||||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||||||
| RoadzenInc. | ||||
| Unaudited Condensed Consolidated Statements of Cash Flow | ||||
| (in US $, except share count) | ||||
| Particulars | For the year ended March 31, | |||
| 2026 | 2025 | |||
| Cash flows from operating activities | ||||
| Net Loss attributable to Ordinary shareholders | (22,516,222 | ) | (72,870,432 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 2,244,268 | 2,020,610 | ||
| Stock based compensation | 497,806 | 47,211,816 | ||
| Deferred income taxes | (14,303 | ) | (193,261 | ) |
| Unrealised foreign exchange loss/(profit) | (831,009 | ) | 132,121 | |
| Gain over liability settled /expenses settled through issuance of equity equity shares | (64,875 | ) | - | |
| Fair value losses/(profits) in financial instruments carried at fair value | 3,984,386 | 14,844,420 | ||
| Impairment of investment | 269,470 | 1,245,326 | ||
| Expected credit loss (net of reversal) | 2,654,182 | 246,115 | ||
| Assets written off | 82,032 | - | ||
| Balances written off/(back) | (1,545,749 | ) | (8,143,051 | ) |
| Gain on extinguishment of intercompany financial assets and liabilities | (482,689 | ) | - | |
| Net total loss attributable to non-controlling interest, net of tax | (500,940 | ) | (192,879 | ) |
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | ||||
| Inventories | 85,980 | (131,868 | ) | |
| Accounts receivables, net | (4,776,282 | ) | 780,880 | |
| Prepayments and other assets | (3,159,457 | ) | (4,822,952 | ) |
| Accounts payable and accrued expenses | 225,170 | 2,833,077 | ||
| Other liabilities | 3,576,831 | (1,102,120 | ) | |
| Net cash used in operating activities | (20,271,401 | ) | (18,142,198 | ) |
| Cash flows from investing activities | ||||
| Purchase of property and equipment & intangible assets | (1,009,660 | ) | (424,910 | ) |
| Proceeds from sale of mutual fund | 112,847 | 309,289 | ||
| Net cash used in investing activities | (896,813 | ) | (115,621 | ) |
| Cash flows from financing activities | ||||
| Proceeds from issue of ordinary shares | 6,519,429 | 7,073,913 | ||
| Proceeds from issue of equity shares of subsidiary | 6,645,789 | - | ||
| Net proceeds/(payments) from borrowings | 8,279,523 | 3,669,290 | ||
| Proceeds from forward purchase agreement | - | 1,000,000 | ||
| Net cash generated from financing activities | 21,444,741 | 11,743,203 | ||
| Effect of exchange rate changes on cash and cash equivalents | - | 3,168 | ||
| Net (decrease)/increase in cash and cash equivalents (including restricted cash) | 276,527 | (6,511,448 | ) | |
| Cash acquired in business combination | 1,470,453 | - | ||
| Cash and cash equivalents at the beginning of the period (including restricted cash) | 5,053,640 | 11,565,088 | ||
| Cash and cash equivalents at the end of the period (including restricted cash) | 6,800,620 | 5,053,640 | ||
| Reconciliation of cash and cash equivalents | ||||
| Cash and cash equivalents | 6,578,594 | 4,836,576 | ||
| Restricted cash | 222,026 | 217,064 | ||
| Total cash and cash equivalents | 6,800,620 | 5,053,640 | ||
| Supplemental disclosure of cash flow information | ||||
| Cash paid for interest, net of amounts capitalized | 2,742,101 | 1,318,139 | ||
| Non-cash investing and financing activities | ||||
| Consideration payable in connection with acquisitions | 6,407,380 | 8,376,253 | ||
| Interest accrued on borrowings | 3,659,399 | 2,123,633 | ||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||
Non-GAAP Financial Measures This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (Adjusted EBITDA), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.
The following tables reconcile our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
| For the three months ended March 31, | Change amount | % | ||||||
| Particulars | 2026 | 2025 | ||||||
| Net loss | (7,253,912 | ) | (106,967 | ) | (7,146,944 | ) | 6681 | % |
| Adjusted for: | ||||||||
| Other (income)/expense net | 193,775 | (3,861,541 | ) | 4,055,316 | -105 | % | ||
| Interest (income)/expense | 1,871,764 | 714,899 | 1,156,865 | 162 | % | |||
| Gain on bargain purchase | (174,248 | ) | - | (174,248 | ) | 100 | % | |
| Fair value changes in financial instruments carried at fair value(1) | (635,187 | ) | (1,681,725 | ) | 1,046,538 | -62 | % | |
| Gain on deconsolidation of subsidiaries | - | - | - | - | ||||
| Impairment of goodwill and intangibles with definite life | - | - | - | - | ||||
| Impairment of investment | - | - | - | - | ||||
| Impairment of investment | 269,470 | 1,245,326 | (975,856 | ) | -78 | % | ||
| Tax (benefit)/expense | (46,966 | ) | 69,709 | (116,675 | ) | -167 | % | |
| Depreciation and amortization | 1,057,462 | 1,046,539 | 10,923 | 1 | % | |||
| Stock based compensation expense | 285,243 | 76,397 | 208,846 | 273 | % | |||
| Non-cash expenses | 2,556,635 | 493,210 | 2,063,425 | 418 | % | |||
| Non-recurring expenses | 1,437,515 | 386,746 | 1,050,769 | 272 | % | |||
| Adjusted EBITDA | (438,449 | ) | (1,617,407 | ) | 1,178,958 | -73 | % | |
| For the year ended March 31, | Change amount | % | ||||||
| Particulars | 2026 | 2025 | ||||||
| Net loss | (22,516,222 | ) | (72,870,432 | ) | 50,354,210 | -69 | % | |
| Adjusted for: | - | - | ||||||
| Other (income)/expense net | (2,329,515 | ) | (7,073,235 | ) | 4,743,720 | -67 | % | |
| Interest (income)/expense | 7,249,803 | 3,247,831 | 4,001,972 | 123 | % | |||
| Gain on bargain purchase | (174,248 | ) | - | (174,248 | ) | 100 | % | |
| Fair value changes in financial instruments carried at fair value(1) | 3,984,386 | 14,844,420 | (10,860,034 | ) | -73 | % | ||
| Gain on deconsolidation of subsidiaries | - | - | - | 100 | % | |||
| Impairment of goodwill and intangibles with definite life | - | - | - | - | ||||
| Impairment of investment | - | - | - | - | ||||
| Impairment of investment | 269,470 | 1,245,326 | (975,856 | ) | -78 | % | ||
| Tax (benefit)/expense | 20,212 | (13,973 | ) | 34,185 | -245 | % | ||
| Depreciation and amortization | 2,244,268 | 2,020,610 | 223,658 | 11 | % | |||
| Stock based compensation expense | 497,806 | 47,211,816 | (46,714,010 | ) | -99 | % | ||
| Non-cash expenses | 2,990,808 | 1,649,448 | 1,341,360 | 81 | % | |||
| Non-recurring expenses | 4,252,368 | 1,340,062 | 2,912,306 | 217 | % | |||
| Adjusted EBITDA | (3,510,864 | ) | (8,398,127 | ) | 4,887,263 | -58 | % | |
(1) Fair value changes in financial instruments are considered to be financing costs as they relate to convertible notes and the Forward Purchase Agreement. These changes are non-cash as these changes in fair value are affected by the volatility of the Company's share price.

| 3 hours | |
| Jun-23 | |
| Jun-18 | |
| Jun-16 | |
| Jun-15 | |
| May-27 | |
| May-19 | |
| May-06 | |
| May-04 | |
| May-01 | |
| Apr-30 | |
| Apr-29 | |
| Apr-27 | |
| Apr-22 | |
| Apr-14 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite